NIAID Funding News, October 6, 2021

October 6, 2021 NIAID Funding News Read this full edition online at https://www.niaid.nih.gov/grants-contracts/funding-news  Feature Articles  A Summary of September's Advisory Council Meeting Catch up on remarks from NIAID Director Dr. Anthony Fauci and a presentation from guest speaker Dr. Steven Holland, director of NIAID's Division of Intramural Research. Opportunities and Resources Small Businesses—New FOA Seeks Multipurpose Prevention Technologies Develop multipurpose prevention technologies that prevent HIV infection and pregnancy in adolescent and young women while also focusing on health disparity populations that are disproportionately infected. Join Systems Biology Centers To Model Human Pathogens Propose research projects that integrate experimental approaches and computational modeling to test and validate hypotheses of significance to the infectious diseases field. Joint NIH/NSF Opportunity Seeks Transformative Advances Using Data Science The funding initiative centers on developing transformative and translational advances in computer and information science, engineering, mathematics, statistics, and behavioral and cognitive research. In The News Preview the 2021 NIH Virtual Seminar on Program Funding and Grant Administration Whether you're new to NIH awards or have years of experience, the Virtual Seminar is your unique opportunity to learn, share, and meet with NIH and NIAID experts as well as your peers from across the globe. Join NIAID Workshop on Pandemic Preparedness and Prototype Pathogens As part of the workshop, NIAID will request feedback from the scientific community on identifying and prioritizing prototype pathogens within viral families of highest pandemic potential to better develop medical countermeasures. Reminder—Annual Vertebrate Animal Reports Are Due December 1 Your next annual vertebrate animal report should cover the 2021 fiscal year—October 1, 2020, to September 30, 2021—and your institutional official must email the signed report as a PDF by December 1, 2021. Advice Corner For Ancillary Studies, Consider NIH Definitions Carefully You need to assess whether your proposed research qualifies under NIH's definition of a clinical trial, NIH's definition of human subjects research, and HHS's list of exemptions for human subjects research. Reader Questions "What is the threshold to report first-tier subawards and executive compensation under FFATA?" "Can I submit two renewal applications to pursue two different aspects of a single R01 award?" New Funding Opportunities RFA-AI-21-065, Systems Biology for Infectious Diseases (U19, Clinical Trial Not Allowed) RFA-AI-21-074, Notice of Special Interest (NOSI)—Primary Caregiver Technical Assistance Supplements (PCTAS) (Admin Supp, Clinical Trial Optional) RFA-OD-21-007, INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21, Clinical Trial Not Allowed)Allowed) RFA-AI-21-068, Development of Microbiome-Related Approaches for Diagnosis/Mitigation/Treatment of Radiation Injuries (U01, Clinical Trial Not Allowed) RFA-AI-21-060, SUNBEAM - Analysis and Bioinformatics Center (ABC) (UM1, Clinical Trial Not Allowed) Find other announcements at NIAID Opportunities & Announcements. Send suggestions or comments to deaweb@niaid.nih.gov. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to rssproject471@gmail.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107

Tweet

Postingan terkait:

— Wednesday, October 6, 2021 — Add Comment